Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.34 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20845390 | 0.86 | FKBP1A (0.35) | CYP19A1FKBP1ABRD4ALDH1A1GAA | |
| SCHEMBL23948519 | 0.81 | LMNA (0.41) | CYP19A1ALDH1A1GAALMNATSHR | |
| SCHEMBL14589097 | 0.80 | CYP19A1 (0.39) | CYP19A1BRD4ALDH1A1GAA | |
| SCHEMBL15199705 | 0.78 | ALDH1A1 (0.33) | CYP19A1BRD4ALDH1A1GAALMNA | |
| SCHEMBL17614238 | 0.77 | CYP19A1 (0.38) | CYP19A1ALDH1A1GAATSHR | |
| SCHEMBL13071576 | 0.77 | BRD4 (0.39) | CYP19A1BRD4ALDH1A1GAALMNA | |
| SCHEMBL16566171 | 0.76 | CYP19A1 (0.44) | CYP19A1ALDH1A1GAALMNA | |
| SCHEMBL12410325 | 0.76 | CYP19A1 (0.41) | CYP19A1ALDH1A1GAA | |
| SCHEMBL21320248 | 0.76 | CYP19A1 (0.33) | CYP19A1 | |
| SCHEMBL24594822 | 0.75 | LMNA (0.36) | CYP19A1BRD4ALDH1A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022178753-A1 | TARGETING CONJUGATES COMPRISING TARGETING MOIETY BINDING FRAGMENTS AND USES THEREOF | SHANGHAI ALLYGEN BIOLOGICS CO., LTD. (CN) | 2022-09-01 | — | — | WO | disclosed |